Overview

ProAir was a prescription drug approved by the U.S. Food and Drug Administration (FDA) to prevent or treat bronchospasm in people ages 4 or older with reversible obstructive airway disease. ProAir was also indicated to prevent exercise-induced bronchospasm. ProAir was referred to by its drug name, albuterol. 

ProAir was a short-acting beta2-adrenergic agonist (SABA). ProAir was also considered a short-acting bronchodilator. ProAir was believed to work by relaxing and dilating the airways, making it easier to breathe.

How was it taken?

ProAir was taken orally using an inhaler four to six times a day, or 15 to 30 minutes before exercise. ProAir came in two forms. ProAir HFA was an aerosol inhaler. ProAir RespiClick was a powder inhaled using the special RespiClick inhaler.

Side effects

The FDA-approved label for ProAir listed common side effects including headache, dizziness, fast heartbeat, sore throat, cold symptoms, and pain. 

Rare but serious side effects listed for ProAir included cardiovascular problems, paradoxical bronchospasm (bronchospasm caused by taking medication), changes in blood glucose or electrolytes, and hypersensitivity reactions.

For more details about this treatment, visit:

Label: ProAir HFA — Albuterol Sulfate Aerosol, Metered — DailyMed